Session » (0019–0048) Genetics, Genomics & Proteomics Poster

Date: Sunday, October 26, 2025

Time: 10:30AM-12:30PM

Meeting: ACR Convergence 2025

10:30AM-12:30PM: Abstract Number: 0041

A genetically determined, serine-based and phosphorylation-dependent molecular switch regulates the inflammatory potential of human IgA

10:30AM-12:30PM: Abstract Number: 0029

A Novel B Cell Subpopulation Characteristic of IgA Vasculitis Identified by Single-Cell RNA Sequencing

10:30AM-12:30PM: Abstract Number: 0037

A Proteomic Signature Containing TNF Receptor Superfamily Member 10A (TNFRSF10A) and Growth/Differentiation Factor 15 (GDF-15) Improves Prediction of All-Cause Mortality Among Individuals with Gout, Beyond Atherosclerotic Cardiovascular and Other Clinical Risk Factors

10:30AM-12:30PM: Abstract Number: 0046

Association of Genetic Variation in XIST and FTX with Susceptibility to Female-Biased Systemic Autoimmune Disease

10:30AM-12:30PM: Abstract Number: 0024

Biobank-scale genetic mapping identifies the shared genetic landscape of rheumatic and cardiovascular disease

10:30AM-12:30PM: Abstract Number: 0020

Bulk RNA-sequencing of Leukocytoclastic Vasculitis Skin Biopsies Show Upregulation of Leukocyte Migration Genes

10:30AM-12:30PM: Abstract Number: 0035

Clinical and Transcriptomic Heterogeneity in Patients With RA: A Multi-Centric International Study of Anti-TNF Response

10:30AM-12:30PM: Abstract Number: 0028

Computational and Laboratory Identification of Risk-Driving Alleles on Juvenile Idiopathic Arthritis (JIA)-Associated Haplotypes

10:30AM-12:30PM: Abstract Number: 0027

Consistent Method to Generate Hyaline Cartilage from Human Induced Pluripotent Stem Cell-Derived Multi-Tissue Organoids

10:30AM-12:30PM: Abstract Number: 0033

Development and Internal Validation of Two Human Leukocyte Antigen Genetic Risk Scores for Predicting Rheumatoid Arthritis Progression and Anti-Citrullinated Protein Antibody-Positivity

10:30AM-12:30PM: Abstract Number: 0044

DNA Methylation Signatures in Systemic Lupus Erythematosus and Rheumatoid Arthritis Highlight Divergent Immune Pathways

10:30AM-12:30PM: Abstract Number: 0038

DNA Methylation Signatures of Smoking in Labial Salivary Gland Tissue in a Sjögren’s Disease Cohort

10:30AM-12:30PM: Abstract Number: 0021

DoCTIS: A Single Cell RNA-Seq Atlas of Drug Response To Targeted Therapies

10:30AM-12:30PM: Abstract Number: 0025

Expansion and Transcriptional Reprogramming of CD14⁺ and CD16⁺ Monocytes in Behçet’s Disease

10:30AM-12:30PM: Abstract Number: 0045

Genetic regulators of corticosteroid response in hepatic and adipose tissue and risk of adverse metabolic outcomes in patients with rheumatoid arthritis initiating glucocorticoids.

10:30AM-12:30PM: Abstract Number: 0022

Genome-wide association study identifies novel genetic risk factors for rheumatoid arthritis-associated interstitial lung disease

10:30AM-12:30PM: Abstract Number: 0039

Hemophagocytic Lymphohistiocytosis Gene Variants in Severe COVID-19 Cytokine Storm Syndrome

10:30AM-12:30PM: Abstract Number: 0040

Identification Of A Novel, Expressed, Alternatively Spliced FCER1G Protein That Inhibits Receptor Function

10:30AM-12:30PM: Abstract Number: 0030

Immune-related Diagnoses Associated with NOD2 Variants in Human Subjects: A Phenome-wide Association Study

10:30AM-12:30PM: Abstract Number: 0036

Integrated Analysis of Polygenic and Environmental Risk Scores for Late-Onset Systemic Lupus Erythematosus

10:30AM-12:30PM: Abstract Number: 0048

Integrative Spatial Proteomics and Single-Cell RNA Sequencing Unveil Molecular Complexity in Rheumatoid Arthritis for Novel Therapeutic Targeting

10:30AM-12:30PM: Abstract Number: 0023

Longitudinal Proteomic Effects of Hydroxychloroquine in Individuals at Risk of Lupus: Differential Signatures in Progressors and Non-Progressors

10:30AM-12:30PM: Abstract Number: 0034

Meta-Analysis of GWAS data from 10,003 Sjögren’s Disease Cases Identifies Thirteen Sjögren’s Risk Loci.

10:30AM-12:30PM: Abstract Number: 0031

Meta-Analysis of Trans-Disease Microbial Biomarkers of Protection and Pathogenesis in Autoimmune Conditions: Results from the AMP AIM Consortium

10:30AM-12:30PM: Abstract Number: 0047

Monocyte Transcriptomic Signatures Uncover Potential Pathogenic Mechanisms of the APOL1 High Risk Genotype (HRG)

10:30AM-12:30PM: Abstract Number: 0032

Protein Language Model-Guided Homology Identifies Microbial Enzymes Linked to Fibrosis-Prone IgG4-RD and Crohn’s Disease

10:30AM-12:30PM: Abstract Number: 0042

Serum Proteomic Analysis of Cellular Immune Clusters in Psoriatic Arthritis

10:30AM-12:30PM: Abstract Number: 0019

Single cell characterization of the circulating immune system in Sjögren’s Syndrome

10:30AM-12:30PM: Abstract Number: 0043

Single-cell and Spatial Transcriptomic Profiling of Muscle Reveals Inflammatory Mechanisms in Anti-glycyl tRNA Synthetase Syndrome

10:30AM-12:30PM: Abstract Number: 0026

Spatial Proteomic-based Phenotyping of Muscle Stem Cells and their Niches in Myositis

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].